BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2033329)

  • 1. [Oxygenation of St. Thomas' Hospital cardioplegic solutions--effects of myocardial temperature and carbon dioxide].
    Mukaeyama Y; Yamamoto S
    Nihon Kyobu Geka Gakkai Zasshi; 1991 Feb; 39(2):133-43. PubMed ID: 2033329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of myocardial protective effects between GIK solution and St. Thomas solution by use of canine isolated heart-lung preparations].
    Ina H; Yasuda I
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Nov; 37(11):2318-27. PubMed ID: 2693545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sodium aspartate on the recovery of the rat heart from long-term hypothermic storage.
    GaliƱanes M; Chambers DJ; Hearse DJ
    J Thorac Cardiovasc Surg; 1992 Mar; 103(3):521-31. PubMed ID: 1545551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxygenation and consequent pH changes on the efficacy of St. Thomas' Hospital cardioplegic solution.
    von Oppell UO; King LM; Du Toit EF; Owen P; Reichart B; Opie LH
    J Thorac Cardiovasc Surg; 1991 Sep; 102(3):396-404. PubMed ID: 1908927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The optimal oxygenation of cardioplegic solution--the buffer effect of carbon dioxide and pH control].
    Ichikawa H; Yamamoto F; Tanaka K; Murashita T; Yamamoto H; Yoshida S; Fujita T
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Dec; 38(12):2396-400. PubMed ID: 2127055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of oxygenation and/or SOD on addition to St. Thomas' Hospital cardioplegic solution].
    Kihana E
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):347-55. PubMed ID: 8478561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery.
    Karck M; Vivi A; Tassini M; Schwalb H; Askenasy N; Navon G; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1356-64. PubMed ID: 1434717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
    Ledingham SJ; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
    Kempsford RD; Hearse DJ
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St. Thomas' Hospital cardioplegic solution. Beneficial effect of glucose and multidose reinfusions of cardioplegic solution.
    von Oppell UO; Du Toit EF; King LM; Owen P; Dunne T; Reichart B; Opie LH
    J Thorac Cardiovasc Surg; 1991 Sep; 102(3):405-12. PubMed ID: 1881179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of oxygenated St. Thomas' Hospital cardioplegic solution during ischaemic cardiac arrest: improved function, metabolism and ultrastructure.
    Choong YS; Cottier DS; Edgar SG
    J Cardiovasc Surg (Torino); 1993 Oct; 34(5):423-33. PubMed ID: 8282749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intramyocardial pH on functional recovery in neonatal hearts receiving St. Thomas' Hospital cardioplegic solution during global ischemia.
    Iannettoni MD; Bove EL; Fox MH; Groh MA; Bolling SF; Gallagher KP
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):333-43. PubMed ID: 1495295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged cardiac preservation. Evaluation of the University of Wisconsin preservation solution by comparison with the St. Thomas' Hospital cardioplegic solutions in the rat.
    Ledingham SJ; Katayama O; Lachno DR; Yacoub M
    Circulation; 1990 Nov; 82(5 Suppl):IV351-8. PubMed ID: 2225427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term hypothermic storage of the mammalian heart for transplantation: a comparison of three cardioplegic solutions.
    GaliƱanes M; Murashita T; Hearse DJ
    J Heart Lung Transplant; 1992; 11(4 Pt 1):624-35. PubMed ID: 1498125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient hypocalcemic reperfusion does not improve postischemic recovery in the rat heart after preservation with St. Thomas' Hospital cardioplegic solution.
    Chambers DJ; Harvey DM; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):344-56. PubMed ID: 1495296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term preservation of the heart: the effect of infusion pressure during continuous hypothermic cardioplegia.
    Chambers DJ; Takahashi A; Hearse DJ
    J Heart Lung Transplant; 1992; 11(4 Pt 1):665-75. PubMed ID: 1498129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The temperature dependency of the protective properties of the St. Thomas' Hospital cardioplegic solution, the University of Wisconsin solution, and Bretschneider buffered solution].
    Kumada Y; Yamamoto F; Ishikawa T; Kagisaki K; Shimada Y; Ohashi T; Yamamoto H; Hirose H
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Dec; 45(12):1954-60. PubMed ID: 9455106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-aspartate improves the functional recovery of explanted hearts stored in St. Thomas' Hospital cardioplegic solution at 4 degrees C.
    Choong YS; Gavin JB
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):510-7. PubMed ID: 2308369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detrimental effects of temperature on the efficacy of the University of Wisconsin solution when used for cardioplegia at moderate hypothermia. Comparison with the St. Thomas Hospital solution at 4 degrees C and 20 degrees C.
    Amrani M; Ledingham S; Jayakumar J; Allen NJ; Rothery S; Severs N; Yacoub M
    Circulation; 1992 Nov; 86(5 Suppl):II280-8. PubMed ID: 1424014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.